Richard Larson

52PUBLICATIONS

283CO-AUTHORS

Regenerative medicine (incl. stem cells)NeonatologyGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (52)

Sort by Publication Date:

|Jul 13, 2026

Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study.

|May 08, 2026

Long-term Follow-up of a Pediatric Regimen for AYA with Ph-negative ALL: 10-year Survival of CALGB 10403 (Alliance).

|Jan 29, 2026

Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Diyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham

|Dec 15, 2025

Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial.

Jorge E Cortes, Timothy P Hughes, Jianxiang Wang

|Oct 27, 2025

Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post-revumenib therapies.

Miles Thomas, Hannah Johnston, Emily Dworkin

|Aug 14, 2025

Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.

Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova

Pageof 9

Frequent Collaborators

Andrew H Wei

Mark R Litzow

Hartmut Döhner

Anand Ashwin Patel

Krzysztof Mrózek

Paresh Vyas

Maria Teresa Voso

Anjali S Advani

Hagop M Kantarjian

Miguel A Sanz

Frequent Collaborators

Andrew H Wei

Mark R Litzow

Hartmut Döhner

Anand Ashwin Patel